Pirfenidone during the remedy of idiopathic pulmonary fibrosis: an proof-based evaluate of its area in therapy phenobarbital will lower the extent or outcome of pirfenidone by affecting hepatic enzyme CYP1A2 metabolism. Contraindicated. Use of powerful CYP1A2 inducers need to be discontinued just before initiating pirfenidone and averted for the duration https://williamg666zmy0.loginblogin.com/profile